$CAPR is shaping up for a potential repeat of what we saw in November. Short interest has climbed back above 30% of the float, sentiment around FDA approval has pushed the stock down to levels that seem to reflect a …
[removed]
TRUMP has absolutely cratered, plummeting a staggering 98% from its all-time high of $74.34 down to just $1.52. This shows signs of the classic, textbook hallmarks of a pump-and-dump scheme, showing an instantaneous spike right at launch followed by a …
Just curious for those who use DCFs as their basis for any valuations. What discount rates and growth rates you use? Do you use single stage or multi stage growth? I usually use 10 year treasury for discount rate and …
Two things. One: I just want to re-touch on how my All Cap models are just not finding anything, and has turned out to be pretty helpful. These models review around 3000 stocks every night. They are all long models …
Bought 0DTE SPY calls this morning, market ripped 0.4% like I called it. Calls still down 60% — theta and IV crush ate everything before direction mattered. Down to rent money. Being "right" means nothing on 0DTE apparently. Anyone else …
A month ago I argued SpaceX was probably a wonderful business but nowhere near a fair price. Since the post-IPO peak of $225.64 on 16 June the stock has plummeted, briefly slipping below its $135 IPO price. The obvious question …